Full Press Release Details
FOR IMMEDIATE RELEASE
Media Contact: Sarah Huoh, 949-250-5070
Investor Contact: Mark Wilterding, 949-250-6826
EDWARDS LIFESCIENCES ANNOUNCES $750 MILLION ACCELERATED SHARE REPURCHASE
IRVINE, Calif., Nov. 1, 2022 Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement ( ASR ) to repurchase $750 million of Edwards common stock. With this transaction, Edwards has repurchased more than $1.7 billion of shares in 2022.
Under the terms of this ASR, Edwards will receive an initial delivery of approximately 8 million shares and the remainder at the maturity of the ASR. The final number of shares to be repurchased will be based on the volume weighted average share price during the term of the agreement. The company is funding the share repurchase under the ASR with its existing cash.
Following this repurchase, Edwards has approximately $900 million remaining in its share repurchase authorization approved by its Board of Directors.
About Edwards Lifesciences